INVESTIGATIVE REMINDER: Schall Law Firm Encourages Investors in Laboratory Corporation of America Holdings with $100,000 Losses to Contact Firm

LOS ANGELES–(BUSINESS WIRE)–Schall law firma national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Laboratory Corporation of America Holdings (“Labcorp” or “the Company”) (NYSE: HL) for violating securities laws.

The investigation aims to determine whether the Company has made false and/or misleading statements and/or has failed to disclose relevant information to investors. A New York Times article published on January 1, 2022, questions the accuracy of non-invasive prenatal tests, including those offered by Labcorp. According to the article, the company’s tests are incorrect up to 85% of the time. False positives lead to follow-up testing that “can cost thousands of dollars, comes with a low risk of miscarriage, and can’t be done until later in the pregnancy.” This high rate of inaccuracy occurs despite the Company’s use of language emphasizing the accuracy of the test. Based on this news, Labcorp shares fell 5% on January 3, 2022.

If you are a shareholder who has suffered a loss, Click here to participate.

We also encourage you to contact Brian Schall of Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us via the firm’s website at www.schallfirm.comor by email at [email protected]

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to do nothing, you can remain an absent member of the group.

Schall Law Firm represents investors worldwide and specializes in securities class action and shareholder rights litigation.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.

Comments are closed.